๐๐๐ข๐ณ๐๐ซ ๐๐๐๐๐-๐๐ ๐ฏ๐๐๐๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐ ๐ญ๐จ ๐๐ ๐๐% ๐๐๐๐๐๐ญ๐ข๐ฏ๐ ๐ข๐ง '๐ ๐ซ๐๐๐ญ ๐๐๐ฒ ๐๐จ๐ซ ๐ฌ๐๐ข๐๐ง๐๐ ๐๐ง๐ ๐ก๐ฎ๐ฆ๐๐ง๐ข๐ญ๐ฒ'
The coronavirus vaccine being developed by Pfizer and BioNTech has been found to be 90% effective in preventing people from getting the virus.
Phase 3 of Pfizer's trial involved 43,538 participants from six countries. They received two doses of either the immunisation or a placebo, with 90% protected from the virus within 28 days of having their jabs.
"Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID-19," said Pfizer chairman and chief executive Dr Albert Bourla.
Pfizer and BioNTech's vaccine is one of around 12 worldwide in the final stages of testing, but it is the first to produce any results.
www.mylondonchauffeurs.co.uk
